Keyphrases
Portugal
100%
Liver Cirrhosis
66%
Cirrhosis
46%
Hiding in Plain Sight
40%
Disease Treatment
40%
Disease Burden
40%
Treatment Algorithm
40%
Cost of Illness
40%
Antiphospholipid Syndrome
40%
Cancer Disease
40%
Hepatocellular Carcinoma
40%
Barcelona Clinic Liver Cancer
40%
Disease Staging
40%
Budd-Chiari Syndrome
40%
Endoscopic Retrograde Cholangiopancreatography
33%
Hepatitis B
30%
Epidemiology
29%
Anticoagulation
26%
Hospital Admission
25%
Gastroenterology Department
23%
Stent Placement
20%
Malignant Duodenal Obstruction
20%
Esophageal Hematoma
20%
Stent Patency
20%
Screening Endoscopy
20%
Cirrhotic Patients
20%
Varices
20%
Metallic Stent
20%
Malignant Biliary Obstruction
20%
Hepatitis C
20%
Retrospective Review
20%
Baveno VI
20%
Brush Cytology
20%
Positive Diagnosis
20%
Age-dependent
20%
Adult Gastroenterology
20%
Endoscopic Revision
20%
Bile Cytology
20%
COVID-19 Vaccination
20%
Thrombolysis
20%
Ischemic Stroke
20%
Pediatric Patients
20%
Immune Response
20%
Clinical Response
20%
Patient Experience
20%
Prognostic Factors
18%
Clinical Efficacy
16%
Papillae
15%
Self-expandable Metal Stent
15%
Hepatitis B Surface Antigen (HBsAg)
13%
Medicine and Dentistry
Liver Cirrhosis
74%
Budd-Chiari Syndrome
40%
Antiphospholipid Syndrome
40%
Cholestasis
27%
Anticoagulation
26%
Gastroenterology
26%
Endoscopic Retrograde Cholangiopancreatography
25%
Hepatitis B
20%
Pediatrics Patient
20%
Cytotechnology
20%
Patient Experience
20%
Prevalence
20%
Epidemiology of Hepatitis B
20%
Superior Mesenteric Artery Syndrome
20%
COVID-19 Vaccination
20%
Stent Placement
20%
Endoscopy
20%
Brain Ischemia
20%
Hematoma
20%
Esophagus
20%
Blood Clot Lysis
20%
Varices
17%
Stenting
15%
Hepatitis C
14%
Prognostic Factor
13%
Hepatitis B Antigen
13%
Warfarin
13%
Angiography
13%
Interventional Radiology
13%
CT
13%
Effective Treatment
13%
Doppler Ultrasound
13%
Percutaneous Transluminal Angioplasty
13%
Doppler Flowmetry
13%
In-Stent Restenosis
10%
Adverse Event
9%
Esophageal Varices
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Infection
8%
Liver Disease
7%
Platelet
5%
Chronic Liver Disease
5%
Proportional Hazards Model
5%
Symptomatic Treatment
5%
Stricture
5%
Hazard Ratio
5%
Oral
5%
Mouth
5%
Proton-Pump Inhibitor
5%
Antiemetic
5%
